WHO has recognized procalcitonin (PCT) as the only specific biomarker for differentiating inflammation caused by bacterial infection and for guiding antibacterial therapy.
The diagnostic challenge is addressed by a rapid test that determines the nature of inflammation in just 20 minutes, eliminating the need to wait for laboratory results.